Participating in a clinical trial can be a way to benefit from a treatment that is better than the current standard-of-care for any stage of cancer.
Immunotherapy is now part of standard of care for some types of triple negative breast cancer, with much more research ongoing.
Two FDA approvals for immunotherapy treatments highlight cancer research news this summer. But the extremely high costs of new cancer therapies are yet to be addressed.
The Cancer Research Institute fosters research in cancer immunology to develop more effective life-saving treatments for all types of cancer.
Prominent issues in cancer research this year included finding ways to make immune system therapies safer and effective for more patients, and the need to make new cancer medicines more affordable.
Cancer research stories worth following this summer include reports from ASCO on a web app that improves survival for lung cancer patients and a “biosimilar” treatment for the breast cancer drug Herceptin.
The Breast Cancer Research Foundation provides seed grants for studies that have the potential for rapid clinical application in breast cancer.
Stand Up To Cancer funds cancer research “Dream Teams” with a common goal of moving new cancer therapies quickly from the lab to patients.
Cancer research stories worth following this spring include a potential new combination treatment for HER2-positive breast cancer and evidence that a gene assay may help breast cancer patients avoid unnecessary chemotherapy treatment.
Taking a look back at major stories about developments in cancer research and breast cancer in 2015.